(Q83941028)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515501%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Adherence to multiple sclerosis disease-modifying therapies in Ontario is low (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515501%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Janice Wong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515501%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Tara Gomes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515501%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Muhammad Mamdani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515501%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Michael Manno

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515501%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Paul W O'Connor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515501%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515501%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Neurological Sciences

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515501%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515501%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515501%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

429-433

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515501%20AND%20SRC:MED&resulttype=core&format=json

Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100011823

7 January 2021

Persistence with treatment in newly treated middle-aged patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100011823

7 January 2021

Persistence and adherence to disease modifying drugs among patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100011823

7 January 2021

Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100011823

7 January 2021

Long-Term Adherence to Interferon β Therapy in Relapsing-Remitting Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100011823

7 January 2021

Increasing use of disease modifying drugs for MS in Canada.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100011823

7 January 2021

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100011823

7 January 2021

Measuring adherence and persistence to disease-modifying agents among patients with relapsing remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100011823

7 January 2021

Persistence with bisphosphonate therapy in older people

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100011823

7 January 2021

Non-adherence to interferon-beta therapy in Swedish patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100011823

7 January 2021

Factors that influence adherence with disease-modifying therapy in MS.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100011823

7 January 2021

Healthcare resource utilization following switch or discontinuation in multiple sclerosis patients on disease modifying drugs

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100011823

7 January 2021

10.1017/S0317167100011823

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515501%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21515501%20AND%20SRC:MED&resulttype=core&format=json